Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 147 | 3 | SARCOMA//SOFT TISSUE SARCOMA//OSTEOSARCOMA | 65246 |
| 2192 | 2 | SYNOVIAL SARCOMA//SOFT TISSUE SARCOMA//TRABECTEDIN | 5223 |
| 11835 | 1 | TRABECTEDIN//SOFT TISSUE SARCOMA//ET 743 | 979 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TRABECTEDIN | authKW | 3935454 | 17% | 75% | 164 |
| 2 | SOFT TISSUE SARCOMA | authKW | 1091244 | 26% | 14% | 250 |
| 3 | ET 743 | authKW | 937643 | 4% | 79% | 37 |
| 4 | ADVANCED SOFT TISSUE SARCOMA | authKW | 457829 | 2% | 89% | 16 |
| 5 | ECTEINASCIDIN 743 | authKW | 242660 | 1% | 54% | 14 |
| 6 | YONDELIS | authKW | 217287 | 1% | 75% | 9 |
| 7 | SARCOMA UNIT | address | 213871 | 4% | 18% | 37 |
| 8 | ADULT SARCOMA MED TREATMENT UNIT | address | 193148 | 1% | 100% | 6 |
| 9 | METASTATIC SOFT TISSUE SARCOMA | authKW | 162961 | 1% | 56% | 9 |
| 10 | HIGH DOSE IFOSFAMIDE | authKW | 160947 | 1% | 50% | 10 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 25846 | 83% | 0% | 809 |
| 2 | Pharmacology & Pharmacy | 668 | 17% | 0% | 169 |
| 3 | Hematology | 48 | 3% | 0% | 29 |
| 4 | Obstetrics & Gynecology | 5 | 2% | 0% | 15 |
| 5 | Transplantation | 4 | 1% | 0% | 8 |
| 6 | Health Care Sciences & Services | 3 | 1% | 0% | 8 |
| 7 | Toxicology | 3 | 1% | 0% | 13 |
| 8 | Surgery | 2 | 3% | 0% | 32 |
| 9 | Medicine, General & Internal | 0 | 2% | 0% | 21 |
| 10 | Chemistry, Medicinal | 0 | 1% | 0% | 9 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SARCOMA UNIT | 213871 | 4% | 18% | 37 |
| 2 | ADULT SARCOMA MED TREATMENT UNIT | 193148 | 1% | 100% | 6 |
| 3 | INTERDISCIPLINARY SARCOMA | 103011 | 0% | 80% | 4 |
| 4 | METHODOL CLIN PLATFORM | 96574 | 0% | 100% | 3 |
| 5 | ADULT SARCOMA MED ONCOL UNIT | 79229 | 1% | 31% | 8 |
| 6 | ADULT SARCOMA MED UNIT | 64383 | 0% | 100% | 2 |
| 7 | COMPREHENS CANC MUSCULOSKELETAL TUMORS | 64383 | 0% | 100% | 2 |
| 8 | DUKE SARCOMA PROGRAM | 64383 | 0% | 100% | 2 |
| 9 | MUSCULOSKELETAL TUMOR BOARD EXCELLENCE SEVILLA MU | 64383 | 0% | 100% | 2 |
| 10 | NETSARC | 64383 | 0% | 100% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF CANCER | 12097 | 6% | 1% | 62 |
| 2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 10690 | 5% | 1% | 50 |
| 3 | ANNALS OF ONCOLOGY | 9842 | 5% | 1% | 51 |
| 4 | INVESTIGATIONAL NEW DRUGS | 8354 | 3% | 1% | 26 |
| 5 | EXPERT REVIEW OF ANTICANCER THERAPY | 7477 | 2% | 1% | 20 |
| 6 | CURRENT OPINION IN ONCOLOGY | 6450 | 2% | 1% | 17 |
| 7 | CANCER TREATMENT REPORTS | 5245 | 2% | 1% | 19 |
| 8 | ANTI-CANCER DRUGS | 5061 | 2% | 1% | 23 |
| 9 | CURRENT TREATMENT OPTIONS IN ONCOLOGY | 4925 | 1% | 2% | 8 |
| 10 | JOURNAL OF CLINICAL ONCOLOGY | 4268 | 5% | 0% | 47 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TRABECTEDIN | 3935454 | 17% | 75% | 164 | Search TRABECTEDIN | Search TRABECTEDIN |
| 2 | SOFT TISSUE SARCOMA | 1091244 | 26% | 14% | 250 | Search SOFT+TISSUE+SARCOMA | Search SOFT+TISSUE+SARCOMA |
| 3 | ET 743 | 937643 | 4% | 79% | 37 | Search ET+743 | Search ET+743 |
| 4 | ADVANCED SOFT TISSUE SARCOMA | 457829 | 2% | 89% | 16 | Search ADVANCED+SOFT+TISSUE+SARCOMA | Search ADVANCED+SOFT+TISSUE+SARCOMA |
| 5 | ECTEINASCIDIN 743 | 242660 | 1% | 54% | 14 | Search ECTEINASCIDIN+743 | Search ECTEINASCIDIN+743 |
| 6 | YONDELIS | 217287 | 1% | 75% | 9 | Search YONDELIS | Search YONDELIS |
| 7 | METASTATIC SOFT TISSUE SARCOMA | 162961 | 1% | 56% | 9 | Search METASTATIC+SOFT+TISSUE+SARCOMA | Search METASTATIC+SOFT+TISSUE+SARCOMA |
| 8 | HIGH DOSE IFOSFAMIDE | 160947 | 1% | 50% | 10 | Search HIGH+DOSE+IFOSFAMIDE | Search HIGH+DOSE+IFOSFAMIDE |
| 9 | IFOSFAMIDE | 146864 | 7% | 7% | 66 | Search IFOSFAMIDE | Search IFOSFAMIDE |
| 10 | YONDELIS R | 144858 | 1% | 75% | 6 | Search YONDELIS+R | Search YONDELIS+R |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |